Artificial Intelligence
Marcella Milliet Sciorra
The Future of Rare Disease Marketing is Patient-First and Privacy-Safe
Marcella Milliet Sciorra
Most Recent
Artificial Intelligence
The Future of Rare Disease Marketing is Patient-First and Privacy-Safe
Swoop helps brands find, engage, and support rare disease patients earlier through privacy-safe, data-driven solutions.
Communities
HS Patients Share Benefits of GLP-1s on their HS Symptoms
myHSteam patients report GLP-1s reduce HS symptoms as well as impact weight or diabetes management
Swooper Files
Dr. Duré Hussain: A Physician’s Insight, A Digital Innovator’s Vision
Meet Swoop’s VP Medical Strategy and Commercial Consulting Dr. Duré Hussain. She brings a unique clinical perspective to digital healthcare marketing and agentic AI to improve patient outcomes.
Artificial Intelligence
Why AI is Fueling the Growth of Patient Communities
Google’s shift toward AI-generated answers removes blue search links often without clear attribution or context.
Artificial Intelligence
Beyond the Buzz: A Practical Framework for AI-Powered Pharma Marketing
Translate buzzwords into brand strategies that impact patient lives with this webinar featuring Romain Bogaerts.
Katie Carr
Targeting Patients at All Phases of Their Health Journey with Predictive Audiences
Using Swoop’s predictive AI technology, marketers can target patients before they are diagnosed, progress to a new treatment or become non-adherent – and more.
Swoop
Moving on from Cookies with Privacy-Safe Targeting: Why Real World Data Has Been the Solution All Along
As Google’s third-party cookies become obsolete, marketers should turn to privacy-safe targeting solutions based on real world data via Swoop.
Dr. Duré Hussain
Navigating Digital Interaction in Pharma: Why Conversational AI Is the Best Option for Customer Engagement
Here’s why Swoop’s conversational AI is the safest and most effective option for healthcare customer digital interaction.
Swoop
Conversational AI: Transforming Engagement in Pharma Marketing
Swoop has launched conversational AI, addressing the need for real-time, personalized engagement between pharma brands and their audiences.
Eric Redline
Implementing Conversational AI for Always-on Engagement on Brand.com
Swoop’s conversational AI is revolutionizing brand.com engagement by providing personalized, 24/7 interactions that cater to life sciences customers.
Swoop
The Power of Owning Your Audience: Connecting with DTC and HCP Consumers Across Channels for Ideal Engagement
Strategic marketers can create a unified engagement strategy across all channels to increase conversion and Rx lift, treating an audience as an asset.
Swoop
Targeting in 2024: What Brands Need to Know
With 2024 planning underway, it’s time to get strategic about audiences. Swoop explains how to target HCPs and patients with AI to improve engagement.
Swoop
A Look Forward to 2024
In this Roundtable in partnership with MM+M, Swoop uncovers what marketers forecast for next year’s priorities and leading trends.
Eric Peacock
4 Pharma Marketing Moves to Make in 2024; Turnkey tactics to make before third-party cookies go away
As the industry faces the depreciation of third-party cookies, pharma marketers and ad agencies are looking for new ways to effectively target diagnosed patients. Here are four tactics that can be launched in-market within a matter of weeks that allow brands to engage patients where they are – patient communities.
Kate Ludwig
Rethinking TV Advertising: Prioritizing Privacy-Safe Custom Audiences to Increase Conversion and Improve Outcomes
Despite a complex television landscape, healthcare marketers can reach ideal patients with the precision of digital using AI and real world health data.